The DTRG work in clinical research in the diabetes space with tertiary institutions both locally in Victoria, nationally and internationally as well as with patient representative bodies including Diabetes
Victoria and JDRF.

The Sensor Line Combo (SLC) Study

This study explores the performance of an  insulin pump infusion line with a combined  CGM sensor.

The Renal Hybrid-Closed Loop (HCL) Study

This study seeks to improve the care of patients with both diabetes and advanced renal disease.

The FlashGM Study

We are investigating if new device called flash glucose monitoring will improve sugar levels compared to finger prick testing for the treatment of Type 2 Diabetes and are looking for Indigenous participants with Type 2 Diabetes to be part of the study


The EMPOWERMENT Study works to help those living with diabetes expand their knowledge of CGM technology, increasing the benefit it can bring to their care. NOW FULLY RECRUITED

Exercise whilst wearing an insulin pump

The aim of this study is to compare glucose control in adults with type 1 diabetes in response to different durations and intensities of exercise, while using an artificial pancreas ( pump and CGM) , and when a temporary glucose target is set at different time points prior to exercise. NOW FULLY RECRUITED

Becoming a participant:

You may be considering becoming a participant in a diabetes research project.

There are many reasons why this can be beneficial to you and the broader diabetes community.

When in the project , you will receive expert clinical support from specialist doctors, credentialed diabetes educators and sometimes a dietician in certain circumstances

You may see a potential change in your HbA1C and glucose variability whilst in the project and you may gain exposure to new diabetes technologies that are not currently commercially available in Australia

We value your contribution to the project, and your data gathered will add to our data collection objectives. This data will be analysed and will be utilised to help develop clinical guidelines, and sometimes even improve products to relieve the impact and burden of diabetes in the future, and for future generations.